The inflammatory response to cardiac surgery with cardiopulmonary bypass: Should steroid prophylaxis be routine?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 26, Issue 5, 2012, Pages 952-958

  Augoustides, John G T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

atrial fibrillation; bleeding; cardiopulmonary bypass; clinical trials registry; coagulation cascade; complement; contact phase; Dexamethasone for Cardiac Surgery trial; endotoxin; fibrinolysis; intensive care unit; interleukins; ischemia reperfusion; length of stay; meta analysis; mortality; randomized clinical trial; steroids; Steroids In CaRdiac Surgery trial; systemic inflammatory response syndrome; transfusion

Indexed keywords

DEXAMETHASONE; ENDOTOXIN; HYDROCORTISONE; INSULIN; METHYLPREDNISOLONE; PLACEBO; STEROID;

ARTIFICIAL VENTILATION; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; CORONARY ARTERY BYPASS SURGERY; CYTOKINE RELEASE; DEEP HYPOTHERMIC CIRCULATORY ARREST; DRUG EXPOSURE; ENDOTHELIUM INJURY; ENDOTOXEMIA; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN TREATMENT; LENGTH OF STAY; LEUKOCYTE ACTIVATION; LOW DRUG DOSE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE DRUG DOSE; STEROID THERAPY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; HUMANS; INFLAMMATION; MULTICENTER STUDIES AS TOPIC; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEROIDS;

EID: 84865705782     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2012.05.001     Document Type: Review

References (51)

1. S. Wan, J.L. LeClerc, J.L. Vintcent Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies Chest 112 1997 676 692
2. J.H. Levy, K.A. Tanaka Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 75 2003 S715 S720
3. O.J. Warren, A.J. Smith, C. Alexiou The inflammatory response to cardiopulmonary bypass: Part I - Mechanisms of pathogenesis J Cardiothorac Vasc Anesth 23 2009 223 231
4. J.R.S. Day, K.M. Taylor The systemic inflammatory response syndrome and cardiopulmonary bypass Int J Surg 3 2005 129 140
5. I.M. Sainz, R.A. Pixley, R.W. Colman Fifty years of research on the plasma kallikrein-kinin system: From protein structure and function to cell biology and in-vivo pathophysiology Thromb Haemost 98 2007 77 83
6. D. Paparella, T.M. Yau, E. Young Cardiopulmonary bypass induced inflammation: Pathophysiology and treatment - An update Eur J Cardiothorac Surg 21 2002 232 244
7. C. Jennewein, P. Paulus, K. Zacharowski Linking inflammation and coagulation: Novel drug targets to treat organ ischemia Curr Opin Anaesthesiol 24 2011 375 380
8. M. Svyatets, K. Tolani, M. Zhang Perioperative management of deep hypothermic circulatory arrest J Cardiothorac Vasc Anesth 24 2010 644 655
9. S.M. Opal The host response to endotoxin, antipolysaccharide strategies, and the management of severe sepsis Int J Med Microbiol 297 2007 365 377
10. M. Rossi, G. Sganga, M. Mazzone Cardiopulmonary bypass in man: Role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation Ann Thorac Surg 77 2004 612 618
11. S. Kats, J.P.A.M. Schönberger, R. Brands Endotoxin release in cardiac surgery with cardiopulmonary bypass: Pathophysiology and possible therapeutic strategies - An update Eur J Cardiothorac Surg 39 2011 451 458
12. M.A. Chaney Corticosteroids and cardiopulmonary bypass: A review of clinical investigations Chest 121 2002 921 931
13. R.P. Whitlock, F.D. Rubens, E. Young Pro: Steroids should be used for cardiopulmonary bypass J Cardiothorac Vasc Anesth 19 2005 250 254
14. O.J. Warren, A.L. Watret, K.L. de Wit The inflammatory response to cardiopulmonary bypass: Part 2 - Anti-inflammatory therapeutic strategies J Cardiothorac Vasc Anesth 23 2009 384 393
15. C.S. Ng, S. Wan Limiting inflammatory response to cardiopulmonary bypass: Pharmaceutical strategies Curr Opin Pharmacol 12 2012 155 159
16. C.K. Allan, J.W. Newburger, E. McGrath The relationship between inflammatory activation and clinical outcome after infant cardiopulmonary bypass Anesth Analg 111 2010 1244 1251
17. C.F. Sultzer, B. Mackensen, G.H.P. Con Methylprednisolone is not indicated for patients during cardiopulmonary bypass J Cardiothorac Vasc Anesth 19 2005 255 258
18. J.G. Augoustides Use of corticosteroids to prevent atrial fibrillation after cardiac surgery JAMA 298 2007 283
19. R.P. Whitlock, E. Young, J. Noora Pulse low dose steroids attenuate post-cardiopulmonary bypass SIRS: SIRS I J Surg Res 132 2006 188 194
20. R.P. Whitlock, S. Chan, P.J. Devereaux Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: A meta-analysis of randomized trials Eur Heart J 29 2008 2592 2600
21. K.M. Ho, J.A. Tan Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: A dose-response meta-analysis Circulation 119 2009 1853 1866
22. G. Cappablanca, C. Rotunno, T. de Luca Protective effects of steroids in cardiac surgery: A meta-analysis of randomized trials J Cardiothorac Vasc Anesth 25 2011 156 165
23. P.E. Marik, R.F. Fromm The efficacy and dosage effect of corticosteroids for the prevention of atrial fibrillation after cardiac surgery: A systematic review J Crit Care 24 2009 458 463
24. J.M. Dieleman, J. van Paasen, D. van Dijk Prophylactic corticosteroids for cardiopulmonary bypass in adults Cochrane Database Syst Rev 5 2011 CD005566
25. J. Price, R. Tee, B.K. Lam Current use of prophylactic strategies for postoperative atrial fibrillation: A survey of Canadian cardiac surgeons Ann Thorac Surg 88 2009 106 111
26. L. Joyce Invited commentary Ann Thorac Surg 88 2009 110 111
27. J.M. Lutz, U. Panchagnula, J.M. Barker Prophylaxis against atrial fibrillation after cardiac surgery: Effective but not routinely used - A survey of cardiothoracic units in the United Kingdom J Cardiothorac Vasc Anesth 25 2011 90 94
28. K.A. Eagle, R.A. Guyton, R. Davidoff ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1999 guidelines for coronary artery bypass graft surgery) Circulation 110 2004 e340 e437
29. L.D. Hillis, P.K. Smith, J.L. Anderson ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Thorac Cardiovasc Surg 143 2011 4 34
30. R.L. Royster, D.W. Gross Hans, N.D. Kan A multimodal approach to address the inflammation of cardiopulmonary bypass? J Cardiothorac Vasc Anesth 25 2011 e35
31. J.J. Appoo, J.G. Augoustides, A. Pochettino Perioperative outcome in adults undergoing elective deep hypothermic circulatory arrest with retrograde cerebrla perfusion in proximal aortic arch repair: Evaluation of protocol-based care J Cardiothorac Vasc Anesth 20 2006 3 7
32. D. Shum-Tim, C.I. Tchervenkov, A.M. Jamal Systemic steroid pretreatment improves cerebral protection after circulatory arrest Ann Thorac Surg 72 2001 1465 1471
33. J.H. Shuhaiber Evaluating the quality of hypothermic circulatory arrest aortic surgery Asian Cardiovasc Thorac Ann 15 2007 449 452
34. A.T. Dewhurst, S.J. Moore, J.B. Liban Pharmacological agents as cerebral protectants during deep hypothermic circulatory arrest in adult thoracic aortic surgery - A survey of current practice J Anesth 57 2002 1016 1021
35. J.G. Augoustides, T.F. Floyd, M.L. McGarvey Major clinical outcomes in adults undergoing thoracic aortic surgery requiring deep hypothermic circulatory arrest: Quantification of organ-based perioperative outcome and detection of opportunities for perioperative intervention J Cardiothorac Vasc Anesth 19 2006 446 452
36. J.G. Augoustides, A. Pochettino, E.A. Ochroch Renal dysfunction after thoracic aortic surgery requiring deep hypothermic circulatory arrest: Definition, incidence, and clinical predictors J Cardiothorac Vasc Anesth 20 2006 673 677
37. S. Robertson-Malt, B. Afrane, M. Elbarbary Prophylactic steroids for paediatric open heart surgery Cochrane Database Syst Rev 4 2007 CD005550
38. R. Heying, E. Wehage, K. Schumacher Dexamethasone pretreatment provides anti-inflammatory and myocardial protection in neonatal arterial switch operation Ann Thorac Surg 93 2012 869 876
39. E.M. Graham, A.M. Atz, R.J. Butts Standardized preoperative corticosteroid treatment in neonates undergoing cardiac surgery: Results from a randomized trial J Thorac Cardiovasc Surg 142 2011 1523 1529
40. S.K. Pasquali, J.S. Li, X. He Perioperative methylprednisolone and outcome in neonates undergoing heart surgery Pediatrics 129 2012 e385 e391
41. S.K. Pasquali, M. Hall, J.S. Li Corticosteroids and outcome of children undergoing congenital heart surgery: Analysis of the Pediatric health information systems database Circulation 122 2010 2123 2130
42. K.J. Jenkins, K. Gauvreau, J.W. Newburger Consensus-based method for risk adjustment for surgery for congenital heart disease J Thorac Cardiovasc Surg 123 2002 110 118
43. K.F. Welke, B.S. Diggs, T. Karamlou Comparison of pediatric cardiac surgical mortality rates from national administrative data to contemporary clinical standards Ann Thorac Surg 87 2009 216 223
44. S.H. Larsen, J. Pedersen, J. Jacobsen The RACHS-1 risk categories reflect mortality and length of stay in a Danish population of children operated for congenital heart disease Eur J Cardiothorac Surg 28 2005 877 881
45. N.A. Clarizia, C. Manihiot, S.M. Schwartz Improved outcomes associated with intraoperative steroid use in high-risk pediatric cardiac surgery Ann Thorac Surg 91 2011 1222 1227
46. F. Lacour-Gayet, D.R. Clarke Aristotle Committee The Aristotle method: A new concept to evaluate quality of care based on complexity Curr Opin Pediatr 17 2005 412 417
47. S.M. O'Brien, J.P. Jacobs, D.R. Clarke Accuracy of the Aristotle basic complexity score for classifying the mortality and morbidity potential of congenital heart surgery operations Ann Thorac Surg 84 2007 2027 2037
48. P.A. Checchia, R.A. Bronicki, J.M. Costello Steroid use before pediatric cardiac operations using cardiopulmonary bypass: An international survey of 36 centers Pediatr Crit Care Med 6 2005 441 444
49. M. Allen, S. Sundararajan, N. Pathan Anti-inflammatory modalities: Their current use in pediatric cardiac surgery in the United Kingdom and Ireland Pediatr Crit Care Med 10 2009 341 345
50. J.J. Zimmerman Development of reliable methods supporting adjunctive therapy for congenital heart surgery Pediatr Crit Care Med 10 2009 410 412
51. J.R. Kallmann, D.B. Andropoulos, P.A. Checchia Report of the pediatric heart network and National Heart, Lung, and Blood Institute working group on the perioperative management of congenital heart disease Circulation 121 2010 2766 2772